BioLife Solutions's market cap is currently ―. The company's EPS TTM is $-1.52; its P/E ratio is -11.53; BioLife Solutions is scheduled to report earnings on May 9, 2024, and the estimated EPS forecast is $-0.32. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 23	Sep 23	Jun 23	Mar 23	Dec 22
Income Statement	-
Total Revenue	$ 32.73M	$ 33.33M	$ 39.51M	$ 31.59M	$ 44.26M
Gross Profit	$ 14.00M	$ 16.66M	$ 11.81M	$ 23.66M	$ -30.29M
EBIT	$ -13.43M	$ -29.02M	$ -10.19M	$ -13.62M	$ -49.79M
EBITDA	$ -11.29M	$ -26.00M	$ -7.10M	$ -10.82M	$ -48.33M
Net Income Common Stockholders	$ -13.38M	$ -29.13M	$ -20.40M	$ 88.90M	$ -107.52M
Balance Sheet	-
Cash, Cash Equivalents and Short-Term Investments	$ 51.70M	$ 41.03M	$ 46.29M	$ 54.92M	$ 62.73M
Total Assets	$ 412.71M	$ 411.15M	$ 433.18M	$ 446.47M	$ 450.23M
Total Debt	$ 42.69M	$ 44.20M	$ 44.57M	$ 43.22M	$ 43.71M
Net Debt	$ -9.00M	$ 3.17M	$ -1.72M	$ -11.70M	$ -19.02M
Total Liabilities	$ 75.05M	$ 79.14M	$ 81.05M	$ 88.36M	$ 86.04M
Stockholders Equity	$ 337.66M	$ 332.02M	$ 352.13M	$ 358.11M	$ 364.19M
Cash Flow	-
Free Cash Flow	$ 1.33M	$ -6.06M	$ -8.14M	$ -6.01M	$ 3.41M
Operating Cash Flow	$ 2.31M	$ -4.57M	$ -7.53M	$ -2.71M	$ 7.86M
Investing Cash Flow	$ 3.96M	$ 1.86M	$ 9.09M	$ 2.93M	$ -14.89M
Financing Cash Flow	$ 9.84M	$ 608.00K	$ 704.00K	$ -562.00K	$ -625.00K

Currency in USD

BioLife Solutions Earnings and Revenue History

Income Statement >

BioLife Solutions Debt to Assets

Balance Sheet >

BioLife Solutions Cash Flow

Cash Flow >

BioLife Solutions Forecast EPS vs Actual EPS

Earnings >

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing